MyFinsight
Home
Blog
About
Net proceeds from
convertible debt
$150K
something is missing
$50K
Proceeds from short term
loans, others
$40.922K
(-86.13%↓ Y/Y)
Proceeds from sales of
common stock under...
$6.63K
Net cash provided by
financing activities
$214.597K
(-27.26%↓ Y/Y)
Canceled cashflow
$32.955K
Net increase in cash
$122.4K
(6362.51%↑ Y/Y)
Canceled cashflow
$92.197K
Repaid to related
party/others
$32.955K
Stock-based compensation
$730.41K
Accounts payable and
accrued liabilities
$402.245K
(96.31%↑ Y/Y)
Net loss
$341.011K
(321.70%↑ Y/Y)
Amortization of debt discount
and deferred...
$156.431K
(92.90%↑ Y/Y)
Accounts payable to
related party
$0.513K
(-50.05%↓ Y/Y)
Net cash used in
operating activities
-$92.197K
(68.54%↑ Y/Y)
Canceled cashflow
$1,630.61K
Gain on
derecognition of...
$1,100K
Change in fair value
equity investment
$300K
Prepaids and other
current assets
$219.939K
(14690.79%↑ Y/Y)
Change in fair value of
derivative
$102.868K
(-75.79%↓ Y/Y)
Back
Back
Cash Flow
Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics, Inc. (OTLC)
source: myfinsight.com